(Q38799071)

6 September 2017

Current State of Opioid Therapy and Abuse (English)

1 reference

6 September 2017

1

Laxmaiah Manchikanti

1 reference

6 September 2017

3

Alan D Kaye

1 reference

6 September 2017

2

Adam M Kaye

1 reference

6 September 2017

language of work or name

English

0 references

publication date

1 May 2016

1 reference

Current Pain and Headache Reports

6 September 2017

1 reference

6 September 2017

20

1 reference

6 September 2017

5

1 reference

6 September 2017

34

1 reference

https://scigraph.springernature.com/pub.10.1007/s11916-016-0564-x

6 September 2017

0 references

cites work

Trends in opioid analgesic abuse and mortality in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Opioids for low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

The global burden of neck pain: estimates from the global burden of disease 2010 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

The global burden of low back pain: estimates from the Global Burden of Disease 2010 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

The economic costs of pain in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Expenditures and health status among adults with back and neck problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Addressing prescription opioid overdose: data support a comprehensive policy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Opioid overuse pain syndrome (OOPS): the story of opioids, prometheus unbound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Prescription opioid abuse: Problems and responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Lessons learned in the abuse of pain-relief medication: a focus on healthcare costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Hydrocodone bitartrate for chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Trends in medical use and abuse of opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Opioids for chronic noncancer pain: still no evidence for superiority of sustained-release opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Prescribing opioid analgesics for chronic non-malignant pain in general practice - a survey of attitudes and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Prescription of opioid analgesics and related harms in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Extent of illicit drug use and dependence, and their contribution to the global burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

The disease of addiction: origins, treatment, and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Alterations in brain structure and functional connectivity in prescription opioid-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Prescription opioid analgesics rapidly change the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Chronic use of opioid analgesics in non-malignant pain: report of 38 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

A 33-year follow-up of narcotics addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Research gaps on methadone harms and comparative harms: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

State laws regulating prescribing of controlled substances: balancing the public health problems of chronic pain and prescription painkiller abuse and overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Development of an opioid reduction protocol in an emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Opioid Dependence vs Addiction: A Distinction Without a Difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Opioid poisonings in Washington State Medicaid: trends, dosing, and guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Combating the prescription painkiller epidemic: a national prescription drug reporting program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Prescription drug monitoring programs: examining limitations and future approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

The role of abuse-deterrent formulations in countering opioid misuse and abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Tamper-resistant drugs cannot solve the opioid crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

A systematic review of community opioid overdose prevention and naloxone distribution programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Preventing and Treating Narcotic Addiction--Century of Federal Drug Control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Harms of prescription opioid use in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Confluence, Not Conflict of Interest: Name Change Necessary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-016-0564-X

Guidelines warfare over interventional techniques: is there a lack of discourse or straw man?

21 January 2018

1 reference

12 December 2020

[U.S. Food and Drug Administration (FDA) strengthens warning that non-aspirin non steroidal anti-inflammatory drugs (NSAIDs) can cause myocardial infarctions or strokes: the dentist's perspective]

1 reference

12 December 2020

Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies.

1 reference

12 December 2020

Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain

1 reference

12 December 2020

Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain.

1 reference

12 December 2020

Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use.

1 reference

12 December 2020

Utility of oral fluid in compliance monitoring of opioid medications

1 reference

12 December 2020

Recent Developments in Prescription Opioid-related Dispensing and Harm Indicators in Ontario, Canada

1 reference

12 December 2020

Reducing opioid analgesic deaths in America: what health providers can do

1 reference

12 December 2020

Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): a public law for balancing treatment of pain and drug abuse and diversion.

1 reference

12 December 2020

Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations

1 reference

12 December 2020

Opioid therapy in the treatment of chronic pain conditions in Germany.

1 reference

12 December 2020

Implementation of an opioid management initiative by a state Medicaid program

1 reference

12 December 2020

Economic burden of prescription opioid misuse and abuse

1 reference

12 December 2020

Prescription opioid analgesics for pain management in Australia: 20 years of dispensing

1 reference

12 December 2020

Zohydro approval by food and drug administration: controversial or frightening?

1 reference

12 December 2020

Does adherence monitoring reduce controlled substance abuse in chronic pain patients?

1 reference

12 December 2020

Methadone for pain and the risk of adverse cardiac outcomes

1 reference

12 December 2020

Prescription Opioid Use, Harms and Interventions in Canada: A Review Update of New Developments and Findings since 2010

1 reference

12 December 2020

Do patient-perceived pros and cons of opioids predict sustained higher-dose use?

1 reference

12 December 2020

Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison

1 reference

12 December 2020

Vital signs: overdoses of prescription opioid pain relievers and other drugs among women--United States, 1999-2010.

1 reference

12 December 2020

A prospective evaluation of psychotherapeutic and illicit drug use in patients presenting with chronic pain at the time of initial evaluation

1 reference

12 December 2020

[S3 guidelines on long-term opioid treatment in non-cancer pain. Recommendations for opioid use in clinical rheumatology]

1 reference

12 December 2020

10.1007/S11916-016-0564-X

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1050684539

0 references

Fatcat ID

release_6outgna7hzaxrmjpjybomwqbwm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6outgna7hzaxrmjpjybomwqbwm

24 November 2022

mapped directly with Wikidata item

1 reference